BIB ETF
ProShares Ultra Nasdaq Biotechnology
BIB ETF Overview
BIB ETF (ProShares Ultra Nasdaq Biotechnology) is managed by ProShares with $88.1M in net assets. BIB expense ratio is 0.95%, holding 261 positions across sectors including Health Care, Information Technology, Financials. Inception date: 2010-04-06.
BIB performance shows a YTD return of 21.16%. The 1-year return is 92.04% and the 5-year return is 0.34%. BIB dividend yield stands at 0.33%, paid quarterly.
BIB top holdings include Ois COP Ibr/8.69000 12/26/24-7Y Cme (44.0%), Sold CNH Bought USD 20251016 (39.6%), Apr27 Ivv Us P @ 587.89 (30.4%), Treasury Bond 3.38 11/15/2048 (26.9%), Mars, Inc. 5.70% 5/1/2055 (20.2%). Go to all BIB holdings, BIB sectors, or BIB dividends.
BIB can be compared against other funds. Use BIB overlap to find shared positions, or BIB vs another fund for a side-by-side view. BIB alternatives are available via the screener, along with tax-loss harvesting opportunities.